Mounjaro 穆峰达 (Tirzepatide) 2.5–10mg/0.5mL Multi-Dose Pen | Eli Lilly China | GLT

Generic Information: Mounjaro / 穆峰达 (Tirzepatide) — China Mainland Presentation by Eli Lilly

This listing is the China Mainland presentation of Mounjaro, the originator tirzepatide that Chinese prescribers know as 穆峰达. The molecule comes from Eli Lilly and Company, and mainland regulators approved it in May 2024 as the first dual GIP/GLP-1 receptor agonist cleared for use in China. Unlike the six-dose ladder sold in the United States, the Chinese Mounjaro label carries four strengths — 2.5 mg, 5 mg, 7.5 mg and 10 mg — supplied in a multi-dose prefilled pen that holds 2.4 mL and delivers four weekly injections. Each carton is sealed with mainland batch numbers and Chinese labeling, which is exactly what hospitals and pharmacies across China verify against the NMPA registry.

What Is Mounjaro (Tirzepatide) Used For?

In mainland China, Mounjaro (穆峰达) carries two formal indications. The first is to improve blood sugar control in adults with type 2 diabetes whose glucose remains poorly controlled on metformin and/or a sulfonylurea, alongside diet and exercise. The second is long-term weight management in adults with an initial body-mass index of 28 kg/m² or more (obese), or 24 kg/m² or more (overweight) with at least one weight-related condition such as hypertension, dyslipidemia, hyperglycemia, obstructive sleep apnea or cardiovascular disease. The China label also covers moderate-to-severe obstructive sleep apnea in adults with obesity, mirroring the expanded US indication.

How Does Mounjaro (Tirzepatide) Work?

Tirzepatide is a single molecule that activates two incretin receptors at once: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Acting on both, it raises first- and second-phase insulin secretion only when blood sugar is actually high, suppresses glucagon release, slows how quickly the stomach empties, and dampens appetite through central pathways. This dual action is why it achieves deeper glucose lowering and, in the registration trials, greater weight reduction than GLP-1 agonism alone. Because it is a peptide, it is given as a once-weekly subcutaneous injection rather than a tablet.

NMPA-Approved Indications (China Label)

The Chinese approval covers, first, type 2 diabetes as an adjunct to diet and exercise in adults inadequately controlled on metformin and/or sulfonylureas; second, chronic weight management in adults with BMI 28 or higher, or BMI 24 or higher with a weight-related comorbidity; and third, moderate-to-severe obstructive sleep apnea in adults with obesity. These mirror but do not extend the US Zepbound obesity label, so mainland prescribers stay within the four available pen strengths. Anyone considering it for type 1 diabetes should know that population is explicitly outside the label.

Dosage and Administration

The pen is injected under the skin of the abdomen, thigh or upper arm once a week, at any time of day and with or without food. Treatment starts at 2.5 mg weekly for four weeks — a starting dose meant for tolerability rather than full glucose control — then steps up to 5 mg weekly. When more control is needed, the dose rises in 2.5 mg increments after at least four weeks on the current dose, up to the Chinese maximum of 10 mg weekly. The four-dose multi-dose pen is for a single patient only and is discarded after four uses; injection sites are rotated each week, and a missed dose within four days is taken promptly, otherwise skipped in favor of the next scheduled injection.

Side Effects of Mounjaro

The common reactions are gastrointestinal and cluster around dose escalation: nausea, vomiting, diarrhea, constipation, reduced appetite and abdominal pain, most of them mild to moderate and fading as the body adjusts. The boxed warning centers on thyroid C-cell tumors seen in rodents — the drug is contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. Other serious possibilities include pancreatitis, gallbladder disease and gallstones, hypoglycemia especially when combined with insulin or a sulfonylurea, and hypersensitivity reactions. Severe, persistent abdominal pain or signs of an allergic reaction warrant immediate medical contact.

Storage Instructions

Keep unopened pens refrigerated at 2°C to 8°C in the original carton and protected from light; do not freeze, and discard any pen that has been frozen. A pen may be held at room temperature up to 30°C for no more than 21 days before first use, after which it should not be returned to the refrigerator. Once the first dose is used, follow the in-use storage window printed on the carton and keep the pen out of children's reach.

Why Choose Mounjaro (穆峰达) from GLT?

Buyers who want the originator molecule with mainland labeling and batch traceability choose this pack. It pairs Lilly provenance with the four-strength China configuration that mainland clinicians are trained on, so a prescription written in China maps directly to what GLT ships. GLT quotes the China original alongside the Bangladesh generics (Tixepa, Tirzema) and the US presentations so the landed cost of every option is visible before a decision is made, and sealed stock with pre-shipment photographs and export documentation comes standard. A real person answers on WhatsApp +86 15234153837 or at [email protected] for every step between quotation and delivery.

How to Order Mounjaro (Tirzepatide)

Message GLT on WhatsApp +86 15234153837 or write to [email protected] with the pen strength, quantity and destination country. A formal quotation with courier options and payment routes returns, usually within one working day; on confirmation, cold-chain-appropriate packaging and complete export paperwork ship the sealed pens. Recurring monthly supply can be scheduled in advance so a continuous weekly course never breaks.

FAQ

Is 穆峰达 the same molecule as US Mounjaro? Identical active ingredient — tirzepatide — sold under the same Mounjaro trade name; 穆峰达 is simply the Chinese registered brand, with a four-strength rather than six-strength pen ladder.

Why does the China pen hold 2.4 mL? The mainland Mounjaro is a multi-dose pen holding four weekly injections of 0.6 mL each; the 2.4 mL total is four doses, not a single shot.

Can the same pen be shared between two people? No — it is a single-patient pen, discarded after four uses, and must never be shared even if needles are changed.

Is tirzepatide insulin? No. It is an incretin-based peptide that nudges the body to release its own insulin only when glucose is elevated; it is not a substitute for insulin and is not indicated for type 1 diabetes.

How quickly does weight loss appear? In the registration program, meaningful weight reduction accrued over months of weekly dosing, with the largest effects seen at higher maintenance doses and alongside sustained dietary and activity changes.